References in periodicals archive ?
3 per cent COPD patients hospitalized for their condition and 26.
Back in 2006, a Canadian Lung Association report [2] pointed out that COPD was "becoming a crucial women's health issue.
COPD Drug Market Overview -- COPD Patient Base: Global, US & Europe -- FDA & EMA Guidelines on Clinical Investigation of COPD Drugs -- COPD Drug Clinical Pipeline by Phase & Country -- COPD Drug in Development Phase: 174 -- Majority of COPD Drugs in Preclinical Phase: 72 -- Marketed COPD Drugs: 36 -- Discontinued & Suspended COPD Drug Profiles
When COPD is severe, shortness of breath and other symptoms can get in the way of even the most basic tasks, such as doing light housework, taking a walk, even washing and dressing.
COPD Assessment Test (Cat) questionnaire was used in this study to see the clinical impact of COPD because it has the advantage of being easier and faster to complete.
So, it is not surprising that the World Health Organisation has predicted that COPD will become the third leading cause of death across the globe, after heart disease and stroke, by 2030," said Professor Cazzola.
COPD is a heterogeneous disease affecting different individuals in different ways.
Rising rates of smoking among women are one causal factor, but more nonsmoking women than men are also being diagnosed with COPD, "so something else is going on with this.
They could not speculate on what exposures may have caused the elevated COPD, but note that other studies have linked agricultural dusts with various respiratory problems.
In the Open Study, which put 160 cases of COPD patients into Mucodyne administration group and control group, Mucodyne proved effective with drastically reduced occurrence of chronic disease in the Mucodyne administered patients.
The fourth-leading cause of death in the United States, COPD is a slowly progressive disease characterized by the obstruction of airflow to the lungs.
Taken together, the company considers that the results suggest an improvement in clinical condition and provide a rationale for moving ThGRF into late-stage development in COPD wasting.